openPR Logo
Press release

Sweeping Reforms in Healthcare Sector will Create Multibillion-dollar Opportunities for Healthcare CMO Market

12-30-2016 12:30 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Sweeping Reforms in Healthcare Sector will Create

Most pharmaceutical and medical devices companies are gradually outsourcing manufacturing activities to contract manufacturers in order to achieve efficiencies in cost, quality, capacity and time to market or to obtain specific expertise in particular business category, which is not available in-house. Moreover, increasing cost pressures, cost benefits and inclination of pharmaceutical companies to focus on core competencies such as R&D and marketing has created a need for outsourcing. Consequently, pharmaceutical and medical device companies are inclined toward outsourcing to concentrate on R&D and marketing of their products by minimizing the time invested in manufacturing practices. The market for contract manufacturing shows tremendous potential due to growth in the medical device industry, growing regulatory concerns and increasing demand from emerging countries.

Obtain the Forthcoming Market Trends of Healthcare CMO at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2452

This research report provides a detailed analysis of the global healthcare contract manufacturing outsourcing (CMO) market and helps in understanding the various driving factors for the growth of the market. The market overview section of this report analyzes the market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of this market. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report in order to deliver a thorough analysis of the overall competitive scenario of the global healthcare CMO market.

The report discusses the healthcare CMO market based on different pharmaceutical and medical device contract manufacturing services. Pharmaceutical contract manufacturing services comprise active pharmaceutical ingredients (API) manufacturing, final dosage formulations (FDF) manufacturing and packaging. Medical device contract manufacturing services include design outsourcing, device manufacturing and final goods assembly.

The global healthcare CMO market has been segmented based on the parameters mentioned above. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments in terms of USD million, considering 2012 as the base year for calculation and 2011 as the historical year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has also been provided along with market size estimations.

The healthcare CMO market by geography has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of World (RoW). The study further offers recommendations and highlights of the market, which would be useful for existing and new market players to sustain and grow in the global healthcare CMO market.

Read the Current Market Analysis of Healthcare CMO at: http://www.transparencymarketresearch.com/healthcare-cmo-market.html

The report concludes with the company profiles section, which includes key information about the major players and market share analysis (value %) of the pharmaceutical contract manufacturing market for the year 2012. Key players profiled in this report include Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Lonza Group, Patheon, Inc., Piramal Healthcare, Accellent, Symmetry Medical, Inc. and Greatbatch, Inc.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sweeping Reforms in Healthcare Sector will Create Multibillion-dollar Opportunities for Healthcare CMO Market here

News-ID: 403672 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for CMO

Healthcare CMO Market
Healthcare CMO Market to 2027 - Global Analysis and Forecasts By Service (Pharmaceutical Contract Manufacturing Services and Medical Device Contract Manufacturing Services), and Geography The global healthcare CMO market is expected to witness substantial growth. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - …
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition Where's your place in the CMO hierarchy? Find out in the CMO industry's authoritative analysis of manufacturing of NDA approvals. This CMO scorecard was compiled through hundreds of professional hours of research and analysis, and is presented in a 40-page report with over 30 graphs and tables. Only CMO Scorecard enables the CMO industry to benchmark its performance
PharmSource-CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance-2018
This report is the 8th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance. CMO Scorecard is critical for benchmarking the performance of the CMO industry and the relative performance of major CMOs. Reasons to buy: This 43-page report gives important, expert insight you won’t find in any other source. 28 tables and figures throughout the report illustrate major points and trends.
CMO Scorecard Market: Outsourcing of NDA Approvals and CMO Performance
Latest industry research report on: CMO Scorecard Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Find out in the CMO industrys authoritative analysis of manufacturing of NDA approvals. This CMO scorecard was compiled through hundreds of professional hours of research and analysis, and is presented in a 40-page report with over 30 graphs and tables. Only CMO Scorecard enables the CMO industry to benchmark its
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report. Request
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report. Request